VOLTAGE-INDEPENDENT CALCIUM CHANNELS MEDIATE SLOW OSCILLATIONS OF CYTOSOLIC CALCIUM THAT ARE GLUCOSE-DEPENDENT IN PANCREATIC BETA-CELLS

被引:41
作者
LEECH, CA
HOLZ, GG
HABENER, JF
机构
关键词
D O I
10.1210/en.135.1.365
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pancreatic beta-cells and HIT-T15 cells exhibit oscillations of cytosolic calcium ([Ca2+](i)) that are dependent on glucose metabolism and appear to trigger pulsatile insulin secretion. Significantly, differences in the pattern of this [Ca2+](i) oscillatory activity may have important implications for our understanding of how glucose homeostasis is achieved during the feeding and fasting states. When single beta-cells are exposed to a stepwise increase in glucose concentration that mimics the transition from fasting to feeding states, fast irregular oscillations of [Ca2+](i) are observed. Alternatively, when single beta-cells are equilibrated in a steady state concentration of glucose that mimics the fasting state, slow periodic oscillations of [Ca2+](i) are noted. Here we report a fundamental difference in the mechanism by which glucose induces these two types of [Ca2+](i) oscillatory activity. In agreement with previous studies, we substantiate a role for L-type voltage-dependent Ca2+ channels as mediators of the fast oscillations of [Ca2+](i) observed after a stepwise increase in glucose concentration. In marked contrast, we report that voltage-independent calcium channels (VICCs) mediate slow oscillations of [Ca2+](i) that occur when beta-cells are equilibrated in steady state concentrations of glucose. Slow [Ca2+](i) oscillations are mediated by VICCs which are pharmacologically and biophysically distinguishable from voltage-dependent Ca2+ channels that mediate fast oscillations. Specifically, slow [Ca2+](i) oscillations are blocked by extracellular La3+, but not by nifedipine, and are independent of changes in membrane potential. Measurements of membrane conductance also indicate an important role for VICCs, as demonstrated by a steady state inward Ca2+ current that is blocked by La3+. The steady state Ca2+ current appears to generate slow [Ca2+](i) oscillations by triggering Ca2+-induced Ca2+ release from intracellular Ca2+ stores, a process that is mimicked by extracellular application of caffeine, a sensitizer of the ryanodine receptor/Ca2+ release channel. Depletion of intracellular Ca2+ stores with thapsigargin stimulated Mn2+ influx, suggesting the presence of Ca2+-release-activated Ca2+ channels. Taken together, these observations are consistent with a role for VICCs (possibly G-type channels) and/or Ca2+-release-activated Ca2+ channels as mediators of slow [Ca2+](i) oscillations in beta-cells. We propose that slow oscillations of [Ca2+](i) probably serve as important initiators of insulin secretion under conditions in which tight control of glucose homeostasis is necessary, as is the case during the fasting normoglycemic state.
引用
收藏
页码:365 / 372
页数:8
相关论文
共 36 条
[1]   CYTOCHROME-P-450 MAY LINK INTRACELLULAR CA2+ STORES WITH PLASMA-MEMBRANE CA2+ INFLUX [J].
ALVAREZ, J ;
MONTERO, M ;
GARCIASANCHO, J .
BIOCHEMICAL JOURNAL, 1991, 274 :193-197
[2]   ELECTROPHYSIOLOGY OF THE PANCREATIC BETA-CELL [J].
ASHCROFT, FM ;
RORSMAN, P .
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 1989, 54 (02) :87-143
[3]   INOSITOL TRISPHOSPHATE AND CALCIUM SIGNALING [J].
BERRIDGE, MJ .
NATURE, 1993, 361 (6410) :315-325
[4]   PERTUSSIS TOXIN STIMULATION OF CATECHOLAMINE RELEASE FROM ADRENAL-MEDULLARY CHROMAFFIN CELLS - MECHANISM MAY BE BY DIRECT ACTIVATION OF L-TYPE AND G-TYPE CALCIUM CHANNELS [J].
CENA, V ;
BROCKLEHURST, KW ;
POLLARD, HB ;
ROJAS, E .
JOURNAL OF MEMBRANE BIOLOGY, 1991, 122 (01) :23-31
[5]  
CORKEY BE, 1988, J BIOL CHEM, V263, P4247
[6]   CYCLIC ADP-RIBOSE - A NEW WAY TO CONTROL CALCIUM [J].
GALIONE, A .
SCIENCE, 1993, 259 (5093) :325-326
[7]  
GILON P, 1993, J BIOL CHEM, V268, P22265
[8]   GLUCOSE-INDUCED OSCILLATIONS OF CYTOPLASMIC CA-2+ IN THE PANCREATIC BETA-CELL [J].
GRAPENGIESSER, E ;
GYLFE, E ;
HELLMAN, B .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 151 (03) :1299-1304
[9]  
GRAPENGIESSER E, 1990, MOL PHARMACOL, V37, P461
[10]  
GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440